Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

William Blair Initiates Coverage On MiNK Therapeutics with Outperform Rating

William Blair analyst Matt Phipps initiates coverage on MiNK Therapeutics (NASDAQ:INKT) with a Outperform rating.

November 9, 2021

1 minute read

William Blair analyst Matt Phipps initiates coverage on MiNK Therapeutics (NASDAQ:INKT) with a Outperform rating.

Wells Fargo Maintains Overweight on Victoria’s Secret, Lowers Price Target to $90

Today, 6:46 AM

Wells Fargo analyst Ike Boruchow maintains Victoria's Secret (NYSE:VSCO) with a Overweight and lowers the price target from $100 to $90.

Today, 6:46 AM

Morgan Stanley analyst Sanjit Singh maintains PagerDuty (NYSE:PD) with a Equal-Weight and raises the price target from $32 to $34.

Today, 6:46 AM

Evercore ISI Group analyst Amit Daryanani maintains Apple (NASDAQ:AAPL) with a Outperform and lowers the price target from $210 to $180.

Today, 6:46 AM

Analysts have provided the following ratings for Domino’s Pizza (NYSE:DPZ) within the last quarter: Bullish Somewhat Bullish Indifferent…